Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment

Heat shock protein 90 (Hsp90) is a highly conserved molecular chaperone that plays a vital role in the signal transduction of cancers. Hsp90 inhibitors are able to inhibit Hsp90 or the complex of Hsp90 and co-chaperones resulting in the degradation of Hsp90-dependent client proteins through the ubiq...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong Li (Author), Dongmei Zhang (Author), Jun Xu (Author), Junmin Shi (Author), Lei Jiang (Author), Nan Yao (Author), Wencai Ye (Author)
Format: Book
Published: Elsevier, 2012-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_787060c1106a466b97f43352c8a7b03f
042 |a dc 
100 1 0 |a Yong Li  |e author 
700 1 0 |a Dongmei Zhang  |e author 
700 1 0 |a Jun Xu  |e author 
700 1 0 |a Junmin Shi  |e author 
700 1 0 |a Lei Jiang  |e author 
700 1 0 |a Nan Yao  |e author 
700 1 0 |a Wencai Ye  |e author 
245 0 0 |a Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment 
260 |b Elsevier,   |c 2012-06-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 2211-3843 
500 |a 10.1016/j.apsb.2012.03.009 
520 |a Heat shock protein 90 (Hsp90) is a highly conserved molecular chaperone that plays a vital role in the signal transduction of cancers. Hsp90 inhibitors are able to inhibit Hsp90 or the complex of Hsp90 and co-chaperones resulting in the degradation of Hsp90-dependent client proteins through the ubiquitination-proteasome pathway, thereby leading to the growth inhibition of tumor cells. This review will briefly discuss the molecular structure and biological function of Hsp90, and focus on a summary of recent progress in the development and testing of natural Hsp90 inhibitors and their different means by which they interact with Hsp90. 
546 |a EN 
690 |a Heat shock protein 90 (Hsp90) 
690 |a Tumor 
690 |a Hsp90 inhibitors 
690 |a Geldanamycin 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 2, Iss 3, Pp 238-245 (2012) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383512000639 
787 0 |n https://doaj.org/toc/2211-3835 
787 0 |n https://doaj.org/toc/2211-3843 
856 4 1 |u https://doaj.org/article/787060c1106a466b97f43352c8a7b03f  |z Connect to this object online.